AYTU vs JAZZ · rev $66.4M vs P/E 1988, rev $2.28B
Aytu BioScience Inc (AYTU) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported AYTU revenue for 2025-06-30 was $66.4M. Net income was -$13.6M. AYTU currently screens at market cap $24.1M.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
AYTU currently screens at market cap $24.1M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the AYTU and JAZZ stock pages for the full models.
Not investment advice.